Rare & Orphan Lab · DeCure for X
DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for balanoposthitis — screening already-approved drugs against its 17-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
No approved-drug candidate for balanoposthitis is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
death associated protein kinase 1 (DAPK1) — DAPK1 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
RCSB Protein Data Bank · entry 2XUU · 1.8 Å · ligand ADENOSINE-5'-DIPHOSPHATE (ADP). Experimental structure, not a prediction.
Balanoposthitis is an inflammatory term covering numerous causes and risk factors, not a single disease. In young men, up to 6% are reported to suffer from balanitis, with prevalence higher in uncircumcised men due to accumulation of microorganisms, secretions and epithelial debris. The 2013 European guideline states that balanoposthitis can be caused by a disparate range of conditions affecting the penile skin, and offers recommendations on diagnostic tests and treatment regimens, but does not report any single drug’s efficacy or survival data. The 2021 NICE Clinical Knowledge Summary review notes that there is little evidence in the paediatric population.
A 2021 case report describes acute spontaneous gangrenous balanoposthitis, first documented in 1883 by Fournier. The authors state that gangrenous and phagedenic balanoposthitis are in most cases a complication of venereal ulcers (ulcus durum, ulcus molle, ulcus mixtum), but can also follow perverted coitus, oral disease, rectal coitus, or traumatic, thermal, chemical, or inappropriate therapy. In some cases vulgar erosions from unclean genital maintenance cause balanoposthitis. The report emphasises that spontaneous gangrenous balanoposthitis can occur in full health without any identifiable cause or preceding coitus, and is extremely intense. No treatment outcomes, response rates, or sample sizes are given.
No abstract provides controlled trial data, survival statistics, or response rates for any drug in balanoposthitis. The evidence consists entirely of guideline summaries and a single case report. What is missing is any randomised trial comparing treatments, any prospective cohort with standardised outcome measures, and any stratification of patients by aetiology (infectious, irritant, autoimmune). Without these, no drug can be claimed to alter the course of the condition.
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
AbstractBalanoposthitis can be caused by a disparate range of conditions affecting the penile skin. This guideline concentrates on a selected group of conditions and offers recommendations on the diagnostic tests and treatment regimens needed for the effective management of balanoposthitis.
https://doi.org/10.1177/0956462414533099AbstractBalanitis is an inflammatory condition typically affecting the glans penis but is commonly associated with inflammation of the foreskin and is consequentially known as ‘balanoposthitis’. It is an illustrative term of which there are numerous causes and risk factors. Among young men, up to 6% are shown to suffer from balanitis.1 Prevalence is higher in uncircumcised men2 due to the accumulation of microorganisms, secretions and epithelial debris between the penis and foreskin.3 In October 2018, the National Institute for Health and Care Excellence (NICE) produced a Clinical Knowledge Summary (CKS) of current evidence. This review will focus on the aspects of the CKS that relate to the paediatric population.4 In NICE CKS, there is little …
https://doi.org/10.1136/archdischild-2020-321303AbstractGangrenous and phagedenic balanoposthitis are in most cases a complication of ulcers of venereal origin: ulcus durum, ulcus molle and ulcus mixtum. Occasionally they appear after a perverted coitus, with diseases of the oral cavity (stomatitis, angina Vincenti), after coitus per rectum (with a disease of the rectum). In some cases, the reasons can be traumatic, thermal, chemical, inappropriate therapy. Often, with unclean maintenance of the genitals, partners after coitus may experience vulgar erosions, which cause balanoposthitis. But often gangrenous and phagedenic balanoposthitis can occur completely independently (spontaneously), when none of the above reasons can be found, even without previous coitus. Such spontaneous gangrenous balanoposthitis was first described in 1883 by Fournier; it is characterized by the fact that it occurs in full health and is extremely intense.
https://doi.org/10.17816/kazmj80457Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
